Impact of Fentanyl Continuous Infusion Dosing Strategies for Analgosedation on Medication Usage

dc.contributor.authorPeters, Michael J.
dc.contributor.authorEllingson, Samantha L.
dc.contributor.authorKimmons, Lauren A.
dc.contributor.authorMarler, Jacob L.
dc.contributor.departmentEmergency Medicine, School of Medicine
dc.date.accessioned2023-09-08T10:33:26Z
dc.date.available2023-09-08T10:33:26Z
dc.date.issued2021
dc.eprint.versionFinal published version
dc.identifier.citationPeters MJ, Ellingson SL, Kimmons LA, Marler JL. Impact of Fentanyl Continuous Infusion Dosing Strategies for Analgosedation on Medication Usage. Hosp Pharm. 2021;56(5):408-409. doi:10.1177/0018578720925371
dc.identifier.urihttps://hdl.handle.net/1805/35480
dc.language.isoen_US
dc.publisherSage
dc.relation.isversionof10.1177/0018578720925371
dc.relation.journalHospital Pharmacy
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectContinuous infusion fentanyl
dc.subjectAnalgosedation
dc.subjectPatient weight
dc.titleImpact of Fentanyl Continuous Infusion Dosing Strategies for Analgosedation on Medication Usage
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554596/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
10.1177_0018578720925371.pdf
Size:
179.13 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: